黄鹏

Hu J, Wu L, Chen X, Li L, Wang T, Huang P, Xu P, Jiang L, Yuan C, Huang M. Genetically encoded near-infrared fluorescent protein probes based on biliverdin enable optical imaging of injury-associated phosphatidylserine in biological systems. Journal of Photochemistry & Photobiology, B: Biology. 2026, 282:113528.

Chen Z, Wu L, Xu H, Niu L, Jiang Y, Xiao X, Jiang L, Xu P, Yuan C, Huang P^{(co-corresponding)}, Huang M. Quaternary counter-ion engineering restores the antibacterial photodynamic activity of aggregation-prone zinc phthalocyanine. Journal of Photochemistry & Photobiology, A: Chemistry. 2026, 481:117444.

Huang J, Tan Y, Huang P, Dong P, Wang X, Raghavan V, Zhong Y, Wang J. Responsive structural colors as interfacial sensors: Mechanism of mass transport and interfacial phenomena. Advances in Colloid and Interface Science. 2026, 355:103936.

Huang P, Wolde T, Bhardwaj V, Zhang X, and Pandey V. TFF3 and PVRL2 co-targeting identified by multi-omics approach as an effective cancer immunosuppression strategy.Life Sciences. 2024, 357:123113.

Huang P, Zhang X, Prabhu JS, and Pandey V. Therapeutic vulnerabilities in triple negative breast cancer: stem-like traits explored within molecular classification.Biomedicine & Pharmacotherapy. 2024, 147:116584.

Wolde T, Huang J,Huang P, Pandey V, and Qin PW. Depleted-MLH1 expression predicts prognosis and immunotherapeutic efficacy in uterine corpus endometrial cancer: an in silico approach.BioMedInformatics. 2024, 4:326-346.

Zhang X, Wang LQ, Chen S,Huang P, Ma L, Ding H, Basappa B, Zhu T, Lobie PE, and Pandey V. Combined inhibition of BADSer99 phosphorylation and PARP ablates models of recurrent ovarian carcinoma.Communications medicine. 2022, 2:82.

Zhang X,Huang P^(co-primary), Wang LQ, Chen S, Basappa B, Zhu T, Lobie PE, and Pandey V. Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma.Cell death & disease. 2022, 12:558.